ArticleJournal of translational medicine2026

CM512, a potentially novel IgG1-based bispecific antibody dual-targeting TSLP and IL-13, for the suppression of type 2 inflammation.

Yunxiao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.